ArticleGastroenterology research and practice2013

Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo.

Song He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.